# Amarantus BioScience Holdings, Inc. (AMBS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AMBS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2023 | $ 1.4K | $ -56.3K | $ 8.6K | $ 19.12M | $ -24.70M |
| 2022 | $ 106.5K | $ -5.32M | $ -5.03M | $ 19.14M | $ -24.67M |
| 2021 | $ 0 | $ -12.12M | $ -11.80M | $ 19.19M | $ -19.93M |
| 2020 | $ 124.5K | $ -236.1K | N/A | N/A | N/A |
| 2019 | $ 25.82M | $ 24.78M | $ 1.6K | $ 20.7K | $ -30.0K |
| 2018 | $ 0 | $ 1.32M | $ 6.56M | $ 18.66M | $ -27.90M |
| 2017 | $ 0 | $ -2.00M | N/A | N/A | N/A |
| 2016 | $ 0 | $ -2.17M | $ -3.42M | $ 3.47M | $ -25.83M |
| 2015 | $ 0 | $ -35.40M | $ -22.50M | $ 2.92M | $ -8.69M |
| 2014 | $ 0 | $ -38.54M | $ -17.11M | $ 222 | $ -4.07M |
| 2013 | $ 0 | $ -25.92M | $ -4.94M | $ 1.06M | $ -7.52M |
| 2012 | $ 0 | $ -7.42M | $ -1.75M | $ 1.51M | $ -3.53M |
| 2011 | $ 66.5K | $ -6.39M | $ -3.10M | $ 927.9K | $ -3.35M |
| 2010 | $ 0 | $ -126.1K | $ -536 | $ 12.5K | $ -102.9K |
| 2009 | $ 1.5K | $ -24.5K | $ -14.7K | $ 11.5K | $ -17.0K |
| 2008 | $ 108 | $ -29.1K | $ -28.7K | $ 2.0K | $ 180 |
| 2007 | $ 180 | $ -2.2K | $ -615 | $ 0 | $ 22.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.77 |
| Liabilities / Eq | -1.41 |
| Current Ratio | 0.00 |

## Other views

- [Metrics](https://sponda.capital/en/AMBS.md)
- [Charts](https://sponda.capital/en/AMBS/charts.md)
- [Compare](https://sponda.capital/en/AMBS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.